Department of Radiation Oncology
Sunil Krishnan has not added Biography.
If you are Sunil Krishnan and would like to personalize this page please email our Author Liaison for assistance.
Antitumor effects of cyclin dependent kinase 9 inhibition in esophageal adenocarcinoma.
Oncotarget Apr, 2017 | Pubmed ID: 28404924
Combination of epidermal growth factor receptor targeted therapy with radiation therapy for malignant gliomas.
Frontiers in bioscience : a journal and virtual library Jan, 2003 | Pubmed ID: 12456322
Genetic and signaling pathway alterations in glioblastoma: relevance to novel targeted therapies.
Frontiers in bioscience : a journal and virtual library May, 2003 | Pubmed ID: 12700121
Choroid plexus papillomas: a single institutional experience.
Journal of neuro-oncology May, 2004 | Pubmed ID: 15174521
Phase II trial of carmustine, cisplatin, and oral etoposide chemotherapy before radiotherapy for grade 3 astrocytoma (anaplastic astrocytoma): results of North Central Cancer Treatment Group trial 98-72-51.
International journal of radiation oncology, biology, physics Feb, 2005 | Pubmed ID: 15667956
Radiosurgery for cranial base chordomas and chondrosarcomas.
Neurosurgery Apr, 2005 | Pubmed ID: 15792516
Intraoperative radiotherapy using a mobile electron LINAC: a retroperitoneal sarcoma case.
Journal of applied clinical medical physics , 2005 | Pubmed ID: 16143794
The optimization of dose delivery for intraoperative high-dose-rate radiation therapy using curved HAM applicators.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology Feb, 2006 | Pubmed ID: 16376445
Phase I trial of erlotinib with radiation therapy in patients with glioblastoma multiforme: results of North Central Cancer Treatment Group protocol N0177.
International journal of radiation oncology, biology, physics Jul, 2006 | Pubmed ID: 16626884
Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer.
American journal of clinical oncology Jun, 2006 | Pubmed ID: 16755173
Adjuvant therapy for ampullary carcinomas: the Mayo Clinic experience.
International journal of radiation oncology, biology, physics Oct, 2006 | Pubmed ID: 16863684
Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer.
International journal of radiation oncology, biology, physics Nov, 2006 | Pubmed ID: 17011451
Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: a matched-pair analysis.
International journal of radiation oncology, biology, physics Dec, 2006 | Pubmed ID: 17056196
Concurrent capecitabine and upper abdominal radiation therapy is well tolerated.
Radiation oncology (London, England) Oct, 2006 | Pubmed ID: 17062148
Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation.
Cancer Dec, 2006 | Pubmed ID: 17083124
Conformal radiotherapy of the dominant liver metastasis: a viable strategy for treatment of unresectable chemotherapy refractory colorectal cancer liver metastases.
American journal of clinical oncology Dec, 2006 | Pubmed ID: 17148992
Correlation between internal fiducial tumor motion and external marker motion for liver tumors imaged with 4D-CT.
International journal of radiation oncology, biology, physics Feb, 2007 | Pubmed ID: 17236980
Predictors and patterns of recurrence after definitive chemoradiation for anal cancer.
International journal of radiation oncology, biology, physics Jul, 2007 | Pubmed ID: 17379452
Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer.
Cancer May, 2007 | Pubmed ID: 17387743
Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products.
Cancer research Apr, 2007 | Pubmed ID: 17440100
Gastrointestinal complications associated with hepatic arterial Yttrium-90 microsphere therapy.
Journal of vascular and interventional radiology : JVIR Apr, 2007 | Pubmed ID: 17446547
Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy.
Cancer Jul, 2007 | Pubmed ID: 17538975
Targeting cell signaling pathways for drug discovery: an old lock needs a new key.
Journal of cellular biochemistry Oct, 2007 | Pubmed ID: 17668425
Clinical benefit of palliative radiation therapy in advanced gastric cancer.
Acta oncologica (Stockholm, Sweden) , 2008 | Pubmed ID: 17899453
Back to basics: how natural products can provide the basis for new therapeutics.
Expert opinion on investigational drugs Nov, 2007 | Pubmed ID: 17970636
Role of adjuvant chemoradiation therapy in adenocarcinomas of the ampulla of vater.
International journal of radiation oncology, biology, physics Mar, 2008 | Pubmed ID: 17980502
Hepatic yttrium-90 radioembolotherapy in metastatic colorectal cancer treated with cetuximab or bevacizumab.
Journal of vascular and interventional radiology : JVIR Dec, 2007 | Pubmed ID: 18057297
Incidence, natural history, and patterns of locoregional recurrence in gastric cancer patients treated with preoperative chemoradiotherapy.
International journal of radiation oncology, biology, physics Jul, 2008 | Pubmed ID: 18164837
4D-CT imaging with synchronized intravenous contrast injection to improve delineation of liver tumors for treatment planning.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology Jun, 2008 | Pubmed ID: 18194819
Daily targeting of liver tumors: screening patients with a mock treatment and using a combination of internal and external fiducials for image-guided respiratory-gated radiotherapy.
Medical physics Dec, 2007 | Pubmed ID: 18196785
Patterns of locoregional recurrence after surgery and radiotherapy or chemoradiation for rectal cancer.
International journal of radiation oncology, biology, physics Jul, 2008 | Pubmed ID: 18207667
Radiotherapy for hepatocellular carcinoma: an overview.
Annals of surgical oncology Apr, 2008 | Pubmed ID: 18236114
Imaging epidermal growth factor receptor expression in vivo: pharmacokinetic and biodistribution characterization of a bioconjugated quantum dot nanoprobe.
Clinical cancer research : an official journal of the American Association for Cancer Research Feb, 2008 | Pubmed ID: 18245533
Curcumin sensitizes human colorectal cancer xenografts in nude mice to gamma-radiation by targeting nuclear factor-kappaB-regulated gene products.
Clinical cancer research : an official journal of the American Association for Cancer Research Apr, 2008 | Pubmed ID: 18381954
Chemoradiation therapy for potentially resectable gastric cancer: clinical outcomes among patients who do not undergo planned surgery.
International journal of radiation oncology, biology, physics May, 2008 | Pubmed ID: 18406886
Modulation of in vivo tumor radiation response via gold nanoshell-mediated vascular-focused hyperthermia: characterizing an integrated antihypoxic and localized vascular disrupting targeting strategy.
Nano letters May, 2008 | Pubmed ID: 18412402
Therapeutic significance of elevated tissue transglutaminase expression in pancreatic cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research Apr, 2008 | Pubmed ID: 18413840
Effect of combining anti-epidermal growth factor receptor antibody C225 and radiation on DU145 prostate cancer.
Oncology reports May, 2008 | Pubmed ID: 18425360
Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Jul, 2008 | Pubmed ID: 18640929
Does neoadjuvant treatment for gastric cancer patients with positive peritoneal cytology at staging laparoscopy improve survival?
Annals of surgical oncology Oct, 2008 | Pubmed ID: 18649106
Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagus.
The American journal of surgical pathology Sep, 2008 | Pubmed ID: 18670347
Neutrophil gelatinase-associated lipocalin: a novel suppressor of invasion and angiogenesis in pancreatic cancer.
Cancer research Aug, 2008 | Pubmed ID: 18676832
Improving soft-tissue contrast in four-dimensional computed tomography images of liver cancer patients using a deformable image registration method.
International journal of radiation oncology, biology, physics Sep, 2008 | Pubmed ID: 18722271
Extrahepatic bile duct adenocarcinoma: patients at high-risk for local recurrence treated with surgery and adjuvant chemoradiation have an equivalent overall survival to patients with standard-risk treated with surgery alone.
Annals of surgical oncology Nov, 2008 | Pubmed ID: 18754070
Modification of the cysteine residues in IkappaBalpha kinase and NF-kappaB (p65) by xanthohumol leads to suppression of NF-kappaB-regulated gene products and potentiation of apoptosis in leukemia cells.
Blood Feb, 2009 | Pubmed ID: 18952893
Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Dec, 2008 | Pubmed ID: 18955445
Proton radiotherapy for liver tumors: dosimetric advantages over photon plans.
Medical dosimetry : official journal of the American Association of Medical Dosimetrists , 2008 | Pubmed ID: 18973852
Attempted salvage resection for recurrent gastric or gastroesophageal cancer.
Annals of surgical oncology Jan, 2009 | Pubmed ID: 18985270
Sacral insufficiency fractures after preoperative chemoradiation for rectal cancer: incidence, risk factors, and clinical course.
International journal of radiation oncology, biology, physics Jul, 2009 | Pubmed ID: 19147305
Frequent loss of heterozygosity of chromosome 1q in esophageal adenocarcinoma: loss of chromosome 1q21.3 is associated with shorter overall survival.
Cancer Apr, 2009 | Pubmed ID: 19156915
Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma.
Annals of surgical oncology Apr, 2009 | Pubmed ID: 19194760
Temporal patterns of fatigue predict pathologic response in patients treated with preoperative chemoradiation therapy for rectal cancer.
International journal of radiation oncology, biology, physics Nov, 2009 | Pubmed ID: 19231100
Intensity-modulated radiation therapy for the treatment of squamous cell anal cancer with para-aortic nodal involvement.
International journal of radiation oncology, biology, physics Nov, 2009 | Pubmed ID: 19231109
Capecitabine and timing of radiotherapy during preoperative chemoradiation for rectal cancer.
Gastrointestinal cancer research : GCR Mar, 2007 | Pubmed ID: 19262718
The role of adjuvant radiation therapy in nonmetastatic gastric cancer: an evolving paradigm.
Gastrointestinal cancer research : GCR Jan, 2009 | Pubmed ID: 19343136
Near-infrared narrow-band imaging of gold/silica nanoshells in tumors.
Journal of biomedical optics Mar-Apr, 2009 | Pubmed ID: 19405772
Respiratory gating with EPID-based verification: the MDACC experience.
Physics in medicine and biology Jun, 2009 | Pubmed ID: 19436104
Spatial distribution, kinetics, signaling and cytokine production during homeostasis driven proliferation of CD4+ T cells.
Molecular immunology Jul, 2009 | Pubmed ID: 19447493
Phase II trial of neoadjuvant bevacizumab, capecitabine, and radiotherapy for locally advanced rectal cancer.
International journal of radiation oncology, biology, physics Mar, 2010 | Pubmed ID: 19464823
Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model.
International journal of cancer. Journal international du cancer Nov, 2009 | Pubmed ID: 19623659
The dosimetric feasibility of gold nanoparticle-aided radiation therapy (GNRT) via brachytherapy using low-energy gamma-/x-ray sources.
Physics in medicine and biology Aug, 2009 | Pubmed ID: 19636084
Hyperfractionated accelerated radiotherapy for rectal cancer in patients with prior pelvic irradiation.
International journal of radiation oncology, biology, physics May, 2010 | Pubmed ID: 19695792
Curcumin modulates the radiosensitivity of colorectal cancer cells by suppressing constitutive and inducible NF-kappaB activity.
International journal of radiation oncology, biology, physics Oct, 2009 | Pubmed ID: 19735878
Local excision after preoperative chemoradiation results in an equivalent outcome to total mesorectal excision in selected patients with T3 rectal cancer.
Annals of surgical oncology Feb, 2010 | Pubmed ID: 19847569
Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer.
International journal of cancer. Journal international du cancer Jul, 2010 | Pubmed ID: 19908231
Reirradiation to the abdomen for gastrointestinal malignancies.
Radiation oncology (London, England) Nov, 2009 | Pubmed ID: 19922641
Modeling of plasmonic heating from individual gold nanoshells for near-infrared laser-induced thermal therapy.
Medical physics Oct, 2009 | Pubmed ID: 19928098
Long-term quality of life after radiotherapy for the treatment of anal cancer.
Cancer Feb, 2010 | Pubmed ID: 20041481
Escin, a pentacyclic triterpene, chemosensitizes human tumor cells through inhibition of nuclear factor-kappaB signaling pathway.
Molecular pharmacology May, 2010 | Pubmed ID: 20103608
A novel small-molecule inhibitor of protein kinase D blocks pancreatic cancer growth in vitro and in vivo.
Molecular cancer therapeutics May, 2010 | Pubmed ID: 20442301
Sesamin manifests chemopreventive effects through the suppression of NF-kappa B-regulated cell survival, proliferation, invasion, and angiogenic gene products.
Molecular cancer research : MCR May, 2010 | Pubmed ID: 20460401
Inhibition of radiation-induced DNA repair and prosurvival pathways contributes to vorinostat-mediated radiosensitization of pancreatic cancer cells.
Pancreas Nov, 2010 | Pubmed ID: 20531243
Long-term survival and recurrence outcomes following surgery for distal rectal cancer.
Annals of surgical oncology Nov, 2010 | Pubmed ID: 20552409
Plumbagin inhibits proliferative and inflammatory responses of T cells independent of ROS generation but by modulating intracellular thiols.
Journal of cellular biochemistry Aug, 2010 | Pubmed ID: 20564204
Gadolinium chloride augments tumor-specific imaging of targeted quantum dots in vivo.
ACS nano Jul, 2010 | Pubmed ID: 20586481
Nonoperative therapies for combined modality treatment of hepatocellular cancer: expert consensus statement.
HPB : the official journal of the International Hepato Pancreato Biliary Association Jun, 2010 | Pubmed ID: 20590905
Targeting inflammatory pathways for tumor radiosensitization.
Biochemical pharmacology Dec, 2010 | Pubmed ID: 20599771
Differential activation of NF-κB and nitric oxide in lymphocytes regulates in vitro and in vivo radiosensitivity.
Mutation research Dec, 2010 | Pubmed ID: 20732448
Estimation of microscopic dose enhancement factor around gold nanoparticles by Monte Carlo calculations.
Medical physics Jul, 2010 | Pubmed ID: 20831089
Nanoparticle-mediated thermal therapy: evolving strategies for prostate cancer therapy.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group , 2010 | Pubmed ID: 20858069
{Gamma}-tocotrienol inhibits pancreatic tumors and sensitizes them to gemcitabine treatment by modulating the inflammatory microenvironment.
Cancer research Nov, 2010 | Pubmed ID: 20864511
Effective Dose from Stray Radiation for a Patient Receiving Proton Therapy for Liver Cancer.
AIP conference proceedings Mar, 2009 | Pubmed ID: 20865142
Thermal enhancement with optically activated gold nanoshells sensitizes breast cancer stem cells to radiation therapy.
Science translational medicine Oct, 2010 | Pubmed ID: 20980696
Methodology for determining doses to in-field, out-of-field and partially in-field organs for late effects studies in photon radiotherapy.
Physics in medicine and biology Dec, 2010 | Pubmed ID: 21076193
Risk of second malignant neoplasm following proton versus intensity-modulated photon radiotherapies for hepatocellular carcinoma.
Physics in medicine and biology Dec, 2010 | Pubmed ID: 21076199
Number of lymph nodes examined and prognosis among pathologically lymph node-negative patients after preoperative chemoradiation therapy for rectal adenocarcinoma.
Cancer Aug, 2011 | Pubmed ID: 21328329
HIF-1-dependent stromal adaptation to ischemia mediates in vivo tumor radiation resistance.
Molecular cancer research : MCR Mar, 2011 | Pubmed ID: 21364021
Intra-organ Biodistribution of Gold Nanoparticles Using Intrinsic Two-photon Induced Photoluminescence.
Lasers in surgery and medicine Sep, 2010 | Pubmed ID: 21399728
Integrin αvβ3-targeted gold nanoshells augment tumor vasculature-specific imaging and therapy.
International journal of nanomedicine , 2011 | Pubmed ID: 21423588
Role of definitive radiation therapy in carcinoma of unknown primary in the abdomen and pelvis.
International journal of radiation oncology, biology, physics Apr, 2012 | Pubmed ID: 21640510
Intensity modulated radiation therapy (IMRT): differences in target volumes and improvement in clinically relevant doses to small bowel in rectal carcinoma.
Radiation oncology (London, England) Jun, 2011 | Pubmed ID: 21651775
Boswellic acid inhibits growth and metastasis of human colorectal cancer in orthotopic mouse model by downregulating inflammatory, proliferative, invasive and angiogenic biomarkers.
International journal of cancer May, 2012 | Pubmed ID: 21702037
Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progression.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Aug, 2011 | Pubmed ID: 21709185
Radiation treatment outcomes for unresectable hepatocellular carcinoma.
Acta oncologica (Stockholm, Sweden) Nov, 2011 | Pubmed ID: 21793641
Decreasing the adverse effects of cancer therapy: an NCI Workshop on the preclinical development of radiation injury mitigators/protectors.
Radiation research Nov, 2011 | Pubmed ID: 21883022
Clinical and prognostic implications of plasma insulin-like growth factor-1 and vascular endothelial growth factor in patients with hepatocellular carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Oct, 2011 | Pubmed ID: 21911725
Zyflamend suppresses growth and sensitizes human pancreatic tumors to gemcitabine in an orthotopic mouse model through modulation of multiple targets.
International journal of cancer Aug, 2012 | Pubmed ID: 21935918
Charged-particle therapy for hepatocellular carcinoma.
Seminars in radiation oncology Oct, 2011 | Pubmed ID: 21939857
Intensity-modulated radiation therapy with concurrent chemotherapy as preoperative treatment for localized gastric adenocarcinoma.
International journal of radiation oncology, biology, physics Jun, 2012 | Pubmed ID: 22137021
Serum sTNF-R1, IL-6, and the development of fatigue in patients with gastrointestinal cancer undergoing chemoradiation therapy.
Brain, behavior, and immunity Jul, 2012 | Pubmed ID: 22251605
Narrow band imaging of squamous cell carcinoma tumors using topically delivered anti-EGFR antibody conjugated gold nanorods.
Lasers in surgery and medicine Apr, 2012 | Pubmed ID: 22415634
In vivo tumor targeting of gold nanoparticles: effect of particle type and dosing strategy.
International journal of nanomedicine , 2012 | Pubmed ID: 22419872
A mouse model for triple-negative breast cancer tumor-initiating cells (TNBC-TICs) exhibits similar aggressive phenotype to the human disease.
BMC cancer Mar, 2012 | Pubmed ID: 22452810
Neoadjuvant treatment response as an early response indicator for patients with rectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology May, 2012 | Pubmed ID: 22493423
Nanoparticle-mediated hyperthermia in cancer therapy.
Therapeutic delivery Aug, 2011 | Pubmed ID: 22506095
Development and validation of a sensitive LC/MS/MS method for the determination of γ-tocotrienol in rat plasma: application to pharmacokinetic studies.
Biomedical chromatography : BMC Jan, 2013 | Pubmed ID: 22522964
Localized gastric cancer treated with chemoradation without surgery: UTMD Anderson Cancer Center experience.
Oncology , 2012 | Pubmed ID: 22677933
Predicting, preventing, treating and understanding radiation nephropathy.
Journal of gastrointestinal oncology Sep, 2010 | Pubmed ID: 22811798
Ursolic acid inhibits growth and metastasis of human colorectal cancer in an orthotopic nude mouse model by targeting multiple cell signaling pathways: chemosensitization with capecitabine.
Clinical cancer research : an official journal of the American Association for Cancer Research Sep, 2012 | Pubmed ID: 22832932
Reproducibility and genital sparing with a vaginal dilator used for female anal cancer patients.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology Aug, 2012 | Pubmed ID: 22841019
Recurrent invasive lobular carcinoma presenting as a ruptured breast implant.
Radiology and oncology Mar, 2012 | Pubmed ID: 22933976
Duodenal toxicity after fractionated chemoradiation for unresectable pancreatic cancer.
International journal of radiation oncology, biology, physics Mar, 2013 | Pubmed ID: 23200173
Extubation after anaesthesia: a randomised comparison of three techniques.
Acta clinica Croatica Sep, 2012 | Pubmed ID: 23330427
Intensity-modulated radiation therapy with concurrent chemotherapy for anal cancer: outcomes and toxicity.
American journal of clinical oncology Oct, 2014 | Pubmed ID: 23466576
Opportunities and challenges in the era of molecularly targeted agents and radiation therapy.
Journal of the National Cancer Institute May, 2013 | Pubmed ID: 23503600
Prevention and Treatment of Colorectal Cancer by Natural Agents From Mother Nature.
Current colorectal cancer reports Mar, 2013 | Pubmed ID: 23814530
KRAS mutations and rectal cancer response to chemoradiation: are we closer to personalization of therapy?
Annals of surgical oncology Oct, 2013 | Pubmed ID: 23864308
Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer.
HPB : the official journal of the International Hepato Pancreato Biliary Association May, 2014 | Pubmed ID: 23991810
Targeting pancreatic cancer with magneto-fluorescent theranostic gold nanoshells.
Nanomedicine (London, England) , 2014 | Pubmed ID: 24063415
Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence-free survival in patients with rectal cancer who undergo resection after neoadjuvant chemoradiotherapy.
Cancer Dec, 2013 | Pubmed ID: 24089344
Metformin use and improved response to therapy in rectal cancer.
Cancer medicine Feb, 2013 | Pubmed ID: 24133632
Combined hyperthermia and radiotherapy for the treatment of cancer.
Cancers Sep, 2011 | Pubmed ID: 24213112
Intensifying local radiotherapy for pancreatic cancer-who benefits and how do we select them?
Journal of gastrointestinal oncology Dec, 2013 | Pubmed ID: 24294503
Preoperative radiation therapy with concurrent capecitabine, bevacizumab, and erlotinib for rectal cancer: a phase 1 trial.
International journal of radiation oncology, biology, physics Feb, 2014 | Pubmed ID: 24315563
Intraoperative radiation therapy for locally advanced primary and recurrent colorectal cancer: ten-year institutional experience.
Journal of surgical oncology Jun, 2014 | Pubmed ID: 24510523
Gold nanoparticles in breast cancer treatment: promise and potential pitfalls.
Cancer letters May, 2014 | Pubmed ID: 24556077
Comparative analysis of volumetric modulated arc therapy versus intensity modulated radiation therapy for radiotherapy of anal carcinoma.
Practical radiation oncology Jul-Sep, 2011 | Pubmed ID: 24673946
Gastric bleeding after radiation therapy for intrahepatic cholangiocarcinoma.
Practical radiation oncology Oct-Dec, 2013 | Pubmed ID: 24674408
Development and validation of insulin-like growth factor-1 score to assess hepatic reserve in hepatocellular carcinoma.
Journal of the National Cancer Institute May, 2014 | Pubmed ID: 24815863
Interobserver variability in target definition for hepatocellular carcinoma with and without portal vein thrombus: radiation therapy oncology group consensus guidelines.
International journal of radiation oncology, biology, physics Jul, 2014 | Pubmed ID: 24969794
Combining radiation and immunotherapy: a new systemic therapy for solid tumors?
Cancer immunology research Sep, 2014 | Pubmed ID: 25187273
Definitive Chemoradiation for Squamous Cell Carcinoma of the Rectum.
American journal of clinical oncology Apr, 2017 | Pubmed ID: 25222072
The rare cancer network: ongoing studies and future strategy.
Rare tumors Jul, 2014 | Pubmed ID: 25276326
Convergence of nanotechnology with radiation therapy-insights and implications for clinical translation.
Translational cancer research Aug, 2013 | Pubmed ID: 25279336
Design of an Yb-169 source optimized for gold nanoparticle-aided radiation therapy.
Medical physics Oct, 2014 | Pubmed ID: 25281948
Zerumbone increases oxidative stress in a thiol-dependent ROS-independent manner to increase DNA damage and sensitize colorectal cancer cells to radiation.
Cancer medicine Feb, 2015 | Pubmed ID: 25450478
Paraneoplastic thrombocytosis independently predicts poor prognosis in patients with locally advanced pancreatic cancer.
Acta oncologica (Stockholm, Sweden) Jul, 2015 | Pubmed ID: 25608822
Targeted gold nanoparticles enhance sensitization of prostate tumors to megavoltage radiation therapy in vivo.
Nanomedicine : nanotechnology, biology, and medicine Jul, 2015 | Pubmed ID: 25652893
Minibeam therapy with protons and light ions: physical feasibility and potential to reduce radiation side effects and to facilitate hypofractionation.
International journal of radiation oncology, biology, physics Jun, 2015 | Pubmed ID: 25771360
HER2/neu-directed therapy for biliary tract cancer.
Journal of hematology & oncology May, 2015 | Pubmed ID: 26022204
Radiotherapy-Induced Malfunction in Contemporary Cardiovascular Implantable Electronic Devices: Clinical Incidence and Predictors.
JAMA oncology Aug, 2015 | Pubmed ID: 26181143
Chemoradiation for High-grade Neuroendocrine Carcinoma of the Rectum and Anal Canal.
American journal of clinical oncology Jul, 2015 | Pubmed ID: 26237193
Vitamin E Analogs as Radiation Response Modifiers.
Evidence-based complementary and alternative medicine : eCAM , 2015 | Pubmed ID: 26366184
Technology for Innovation in Radiation Oncology.
International journal of radiation oncology, biology, physics Nov, 2015 | Pubmed ID: 26460989
Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response Analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Jan, 2016 | Pubmed ID: 26503201
PDL1 Regulation by p53 via miR-34.
Journal of the National Cancer Institute Jan, 2016 | Pubmed ID: 26577528
In Reply to Sahadevan.
International journal of radiation oncology, biology, physics Dec, 2015 | Pubmed ID: 26581155
Charged Particle Therapy with Mini-Segmented Beams.
Frontiers in oncology , 2015 | Pubmed ID: 26649281
Roadmap to Clinical Use of Gold Nanoparticles for Radiation Sensitization.
International journal of radiation oncology, biology, physics Jan, 2016 | Pubmed ID: 26700713
Hyperthermia using nanoparticles--Promises and pitfalls.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group , 2016 | Pubmed ID: 26757879
The evolving evidence for the efficacy and safety of charged particle therapy for hepatocellular carcinoma-a commentary.
Annals of translational medicine Dec, 2015 | Pubmed ID: 26807419
Quantitative imaging of gold nanoparticle distribution in a tumor-bearing mouse using benchtop x-ray fluorescence computed tomography.
Scientific reports Feb, 2016 | Pubmed ID: 26912068
Everything Old Is New Again: Using Nelfinavir to Radiosensitize Rectal Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research Apr, 2016 | Pubmed ID: 26920893
Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach?
Nature reviews. Clinical oncology Aug, 2016 | Pubmed ID: 26951040
Quantitative investigation of physical factors contributing to gold nanoparticle-mediated proton dose enhancement.
Physics in medicine and biology Mar, 2016 | Pubmed ID: 26952844
Focal Radiation Therapy Dose Escalation Improves Overall Survival in Locally Advanced Pancreatic Cancer Patients Receiving Induction Chemotherapy and Consolidative Chemoradiation.
International journal of radiation oncology, biology, physics Mar, 2016 | Pubmed ID: 26972648
Corrigendum to "Targeted gold nanoparticles enhance sensitization of prostate tumors to megavoltage radiation therapy in vivo" [Nanomedicine: Nanotechnology, Biology, and Medicine 11 (2015) 1277-1283].
Nanomedicine : nanotechnology, biology, and medicine Apr, 2016 | Pubmed ID: 27018259
Oncologic and Functional Hazards of Obesity Among Patients With Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiation Therapy.
American journal of clinical oncology Mar, 2016 | Pubmed ID: 27028350
Tumor Cells Surviving Exposure to Proton or Photon Radiation Share a Common Immunogenic Modulation Signature, Rendering Them More Sensitive to T Cell-Mediated Killing.
International journal of radiation oncology, biology, physics May, 2016 | Pubmed ID: 27084634
Pharmacokinetic, biodistribution and therapeutic efficacy of 5-fluorouracil-loaded pH-sensitive PEGylated liposomal nanoparticles in HCT-116 tumor bearing mouse.
Journal of nature and science , 2016 | Pubmed ID: 27200415
Impact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinoma.
Cancer Sep, 2016 | Pubmed ID: 27243381
Phase I Trial of Consolidative Radiotherapy with Concurrent Bevacizumab, Erlotinib and Capecitabine for Unresectable Pancreatic Cancer.
PloS one , 2016 | Pubmed ID: 27336466
Radiotherapy for Hepatocellular Carcinoma: New Indications and Directions for Future Study.
Journal of the National Cancer Institute Sep, 2016 | Pubmed ID: 27377923
DNA Mismatch Repair Deficiency in Rectal Cancer: Benchmarking Its Impact on Prognosis, Neoadjuvant Response Prediction, and Clinical Cancer Genetics.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Sep, 2016 | Pubmed ID: 27432916
Current Insights in Radiation Combination Therapies: Influence of Omics and Novel Targeted Agents in Defining New Concepts in Radiation Biology and Clinical Radiation Oncology.
Seminars in radiation oncology Oct, 2016 | Pubmed ID: 27619246
Recent Advances and Prospects for Multimodality Therapy in Pancreatic Cancer.
Seminars in radiation oncology Oct, 2016 | Pubmed ID: 27619253
Biliary cancer: Utility of next-generation sequencing for clinical management.
Cancer Sep, 2016 | Pubmed ID: 27622582
Preoperative Chemoradiation for Pancreatic Adenocarcinoma Does Not Increase 90-Day Postoperative Morbidity or Mortality.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract Dec, 2016 | Pubmed ID: 27730398
Hyperfractionated Accelerated Reirradiation for Patients With Recurrent Anal Cancer Previously Treated With Definitive Chemoradiation.
American journal of clinical oncology Oct, 2016 | Pubmed ID: 27755060
Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract Oct, 2016 | Pubmed ID: 27778257
H19 Noncoding RNA, an Independent Prognostic Factor, Regulates Essential Rb-E2F and CDK8-β-Catenin Signaling in Colorectal Cancer.
EBioMedicine Nov, 2016 | Pubmed ID: 27789274
Suppression of Type I IFN Signaling in Tumors Mediates Resistance to Anti-PD-1 Treatment That Can Be Overcome by Radiotherapy.
Cancer research Feb, 2017 | Pubmed ID: 27821490
Hyperfractionated accelerated reirradiation for rectal cancer: An analysis of outcomes and toxicity.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology Jan, 2017 | Pubmed ID: 28057329
Does Unintentional Splenic Radiation Predict Outcomes After Pancreatic Cancer Radiation Therapy?
International journal of radiation oncology, biology, physics Feb, 2017 | Pubmed ID: 28068240
Reduced expression of argininosuccinate synthetase 1 has a negative prognostic impact in patients with pancreatic ductal adenocarcinoma.
PloS one , 2017 | Pubmed ID: 28187218
Mitochondrion-Anchoring Photosensitizer with Aggregation-Induced Emission Characteristics Synergistically Boosts the Radiosensitivity of Cancer Cells to Ionizing Radiation.
Advanced materials (Deerfield Beach, Fla.) Apr, 2017 | Pubmed ID: 28195448
Real-time liver uptake and biodistribution of magnetic nanoparticles determined by AC biosusceptometry.
Nanomedicine : nanotechnology, biology, and medicine Feb, 2017 | Pubmed ID: 28214607
The Rise of Radiomics and Implications for Oncologic Management.
Journal of the National Cancer Institute Jul, 2017 | Pubmed ID: 28423406
In Reply to Yazici et al.
International journal of radiation oncology, biology, physics Jun, 2017 | Pubmed ID: 28463175
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유